3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Interventions
Carboplatin
30
pembrolizumab
25
Pemetrexed
25
Specimen Handling
23
Cisplatin
21
Magnetic Resonance Spectroscopy
19
Paclitaxel
14
Gemcitabine
14
Docetaxel
11
durvalumab
8
Nivolumab
8
osimertinib
7
atezolizumab
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
Platinum
6
Cetuximab
6
1,2-diaminocyclohexaneplatinum II citrate
6
Radiation
5
Etoposide
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiosurgery
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
avelumab
×
30 days
×
Clear all
No trials found.